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Background: St Jude Medical “Riata” implantable cardioverter-deﬁbrillator leads have a higher-than-
expected failure rate and carry a Class 1 recall. Failure usually relates to an insulation breach that may not
be identiﬁed by lead ﬂuoroscopic or electrical changes.
Case presentation: We report a case of Riata lead failure identiﬁed by the aborted delivery of effective
therapy for ventricular ﬁbrillation at the time of deﬁbrillation threshold testing. Lead ﬂuoroscopic
appearances were normal. Shock impedance on attempted shock delivery was unrecordably low, and all
other electrical parameters were within normal limits.
Conclusion: Riata lead failure may be unrecognised until there is failure to deliver necessary therapy.
Strong consideration ought to be given to lead examination under high-voltage shock delivery through
the device.
& 2013 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.1. Introduction
The St Jude Medical (SJM) “Riata” family of implantable
cardioverter-deﬁbrillator (ICD) leads have been recalled for high
insulation failure rates. We present a case of a Riata lead that failed
device testing after electrical parameters and radiographic images
were shown to be within normal limits.2. Case report
A 67-year-old man undertook left-sided, prepectoral single
chamber ICD implantation with a SJM Epic+VR V-196 pulse
generator and a SJM Riata 1580, dual-coil lead in 2005. The
implant indication was sustained monomorphic ventricular tachy-
cardia (VT) in the context of a dilated left ventricle (end-systolic
diameter 6.2 cm) with severely impaired systolic function (left
ventricular ejection fraction 15%). His past medical history
includes Starr–Edwards aortic and mitral valve replacements for
rheumatic valve disease, and permanent atrial ﬁbrillation (AF). The
lead was positioned in an apical right ventricular (RV) position
where the pacing threshold was 0.7 V at 0.5 ms, R-wave 13.2 mV,
slew 2.5 V/s, and lead impedance 664 Ω. Device-testing demon-
strated a deﬁbrillation threshold o20 J and shock impedance was
37 Ω.t Rhythm Society. Published by Els
64 7 839 8760.
z (M.K. Stiles).Over two years he received multiple inappropriate shocks for
rapid ventricular rates in AF. The shock impedance at last therapy
in 2006 was 62 Ω. The R-wave sensing dropped from 13.2 mV, to
7.9 mV in 2007, and 5.5 mV in 2009. Due to battery depletion he
came forward for generator replacement in October 2011. We did
not examine shock impedance through the SJM generator. Shock
impedance was not measured on previous checks because of the
inability to deliver a painless sub-threshold test through this
model of SJM generator. The electrical parameters through the
programmer were RV sensing 5.8 mV, pacing threshold 0.5 V at
0.5 ms, and lead impedance 360 Ω. On the advice of device
company representatives we opted to examine shock impedance
through the incumbent Riata lead with a full-output, high voltage
(HV) shock delivered by the new Medtronic generator. Chest X-ray
and lead ﬂuoroscopy had not demonstrated any obvious
abnormalities.
At the time of generator replacement some discolouration was
noted around the pace/sense pin but there was no visible insula-
tion breach. Due to the low sensed R-wave value, we elected to
induce ventricular ﬁbrillation (VF) to examine for undersensing,
rather than deliver a QRS-synchronised shock in stable rhythm.
There was no undersensing of VF, and the device charged appro-
priately to 36 J (J) but only delivered 0.6 J. VF persisted. A second
attempt by the device delivered 0 J (Fig. 1)! VF was terminated via
external rescue shock. Interrogation of the device revealed shock
impedance values less than the detectable threshold of 20 Ω. It
was concluded that an insulation breach with a short-circuit
between the HV cables was likely. The normal appearance of theevier B.V. All rights reserved.
Fig. 1. Electrogram of ventricular ﬁbrillation episode. Arrows denote two attempted shocks by the Medtronic ICD generator via the defective Riata lead with delivered energy
of 0.6 J and 0.0 J respectively.
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suggests there is not a short-circuit between the coil cable and
can. A new lead was delivered via the left subclavian vein with
acceptable sensing in the low RV septum. DFT-testing was then
performed through the new lead and Medtronic generator demon-
strating shock impedance values in the RV and superior vena cava
coils of 33 and 38 Ω respectively. These values suggest normal
generator function and localise the earlier shock impedance issue
to the Riata lead. The Riata lead was capped and left in place.3. Discussion
SJM issued a hazard alert in 2010 advising of insulation defects
in their Riata silicone ICD leads. Based on data to September 2011,
from complaints and returned product analysis, SJM advised of a
0.63% incidence of all-cause abrasion in Riata and Riata ST leads.
By December 2011 the US Food and Drug Administration (FDA)
issued a Class 1 recall on Riata Silicone leads. Recent data suggests
a lead failure rate of approximately 2% per year [1].
The insulation defect has resulted in dramatic “inside-out”
extrusion of the inner cables, [2–5] observed in up to 33% of
patients in one series, [6] and electrical failure in other leads with
normal ﬂuoroscopic appearance. Parvathaneni et al. also observed
that of those leads with cable extrusion, 31% showed electrical
failure. Preservation of electrical function in remaining leads with
extruded cables is attributed to their protective cable ethylenete-
traﬂuoroethylene (ETFE) coating.
Lead failure manifests in several ways. Oversensing of non-
physiologic signal has resulted in inappropriate therapy, [7] and a
short-circuit (between the can and coil or between opposing HV
electrodes by “outside-in” cable extrusion) has resulted in device
failure [8] and death [9]. A recent case report describes the loss of
two brand new generators connected to an incumbent SJM Riata
lead at the time of generator replacement [8]. In our case the
Medtronic generator was saved by aborting energy delivery, a
mechanism incorporated to protect the device if low impedance is
detected, but it failed to deliver appropriate therapy for VF.
An evidence-based strategy for Riata lead follow-up is not yet
established. Fluoroscopic examination of all Riata leads may be
considered, however some electrical failures occur in ﬂuoroscopi-
cally “normal” leads and it is not clear that all insulation breaches
will result in lead failure. In a study examining 133 deaths by leadfailure, 22 deaths were caused in Riata or Riata ST leads none of
which showed lead externalisation [9].
Increased surveillance of electrical parameters may be war-
ranted, yet up to 30% of those with normal electrical data may
demonstrate insulation breach and cable extrusion [6]. There are
at least two other reports of Riata lead failure in which prior
electrical parameters were within acceptable limits [5,10].
As yet there are no independent multicentre data regarding the
incidence of Riata or Riata ST lead failure, the signs of failure, or
their clinical consequences. Similarly, the reliability of electrically
intact externalised cables is unknown. Without such data, it is not
possible to design evidence-based patient management strategies,
or to advise Riata patients of their risks. We keenly await the
published results of the Riata Independent Multicenter Study, a
large, retrospective analysis of 1060 Riata leads implanted
between 2002 and 2008, in seven international centres.
It is apparent from this case that delivering an HV shock may
unmask an otherwise unrecognised, important lead defect and
may be a useful component of Riata lead surveillance. If the shock
is to be delivered in the setting of VF it would be prudent to check
the shock impedance before VF induction to ensure the integrity of
the lead-to-header connection.4. Conclusion
Until there is data to support a consensus statement on the best
follow-up of Riata leads it is our practise to activate remote
monitoring, and undertake three-monthly electrical checks.
Immediately prior to generator replacement we examine the lead
under ﬂuoroscopy and, giving the ﬁndings of this case, deliver a
high-voltage, synchronised shock to an anaesthetised patient in a
stable rhythm, or on induction of VF if there is doubt about sensing
integrity.Conﬂict of Interest
The following potential conﬂicts apply to this manuscript: Dr.
Webber receives fellowship funding from Biosense-Webster and
Dr. Stiles reports performing advisory board work for Boston
Scientiﬁc and having received lecture fees and fellowship funding
from Biosense-Webster and Medtronic.
M.R. Webber et al. / Journal of Arrhythmia 29 (2013) 187–189 189Acknowledgements
We would like to thank the cardiac electrophysiology team at
Waikato Hospital and representatives of St Jude Medical for their
support and contribution to this manuscript.
References
[1] Hodkinson E, Kodoth V, Ashﬁeld K, et al. Follow-up Riata screening in
Northern Ireland. J Am Coll Cardiol 2012;59(13 Suppl S):E585.
[2] Valk S, Luijten R, Jordaens L. Insulation damage in a shock wire: an unexpected
ﬂuoroscopic image. Pacing Clin Electrophysiol 2010;33:770–2.
[3] Richards MW, Warren CE, Anderson MH. Late failure of a single-coil transve-
nous implantable cardioverter-deﬁbrillator lead associated with conductor
separation. Europace 2010;12:1191–2.
[4] Erkapic D, Duray GZ, Bauernfeind T, et al. Insulation defects of thin high-
voltage ICD leads: an underestimated problem? J Cardiovasc Electrophysiol
2011;22:1018–22.[5] Krebsbach A, Alhumaid F, Henrikson CA, et al. Premature failure of a Riata
deﬁbrillator lead without impedance change or inappropriate sensing: a case
report and review of the literature. J Cardiovasc Electrophysiol
2011;22:1070–2.
[6] Parvathaneni SV, Ellis CR, Rottman JN. High prevalence of insulation failure
with externalized cables in St. Jude Medical Riata family ICD leads; ﬂuoro-
scopic grading scale and correlation to extracted leads. Heart Rhythm
2012;9:1218–24.
[7] Hauser RG, McGriff D, Retel LK. Riata ICD lead failure: analysis of explanted
leads with a unique insulation defect. Heart Rhythm 2012;9:742–9.
[8] Leong DP, Erven LV. Unrecognized failure of a narrow caliber deﬁbrillation
lead: the role of deﬁbrillation threshold testing in identifying an unprotected
individual. Pacing Clin Electrophysiol 2012;35:e154–5.
[9] Hauser RG, Abdelhadi R, McGriff D, et al. Deaths caused by the failure of Riata
and Riata ST implantable cardioverter-deﬁbrillator leads. Heart Rhythm
2012;9:1227–35.
[10] Chan CW, Chiang CS. An ICD lead with failure of outer insulation goes
undetected by regular measurements. Pacing Clin Electrophysiol 2012;35:
e261–e262.
